SafetyMargin.ioSafetyMargin.io
BlogWatchlistCompare
Compare Stocks › ABBV vs CPT

AbbVie Inc. (ABBV) vs Camden Property Trust (CPT): Which Is the Better Buy in 2026?

As of 2026-11-01, ABBV is overvalued at $295, with a DCF intrinsic value of $172 and a margin of safety of -71%. CPT is overvalued at $101, with an intrinsic value of $32 and a margin of safety of -218%. Of the two, ABBV has the wider margin of safety.

ABBV
AbbVie Inc.
$294.89
VS
CPT
Camden Property Trust
$100.69

Rewards

ABBV
  • ★AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • ★Gross margin of 73.7% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • ★AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
CPT
  • ★Gross margin of 61.6% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.

Risks

ABBV
  • ⚠Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • ⚠Insiders have sold $8.2M worth of stock in the past 3 months — significant insider liquidation.
  • ⚠Free cash flow has declined at a 9.8% CAGR over the past 4 years — a concerning trend.
CPT
  • ⚠PEG ratio of 9.17 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • ⚠Net debt/EBITDA of 5.4x indicates heavy leverage — it would take over 4 years of EBITDA to pay off net debt.
  • ⚠Altman Z-Score of 1.60 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.

Key Valuation Metrics

Learn more →
ABBV
CPT
Valuation
N/A
Free Cash Flow
$386.22M
N/A
FCF Yield
3.31%
50.67
Trailing P/E
33.23
18.24
Forward P/E
134.25
Quality & Moat
29.08%
ROIC
2.30%
N/A
ROE
7.89%
73.72%
Gross Margin
61.62%
0.60
PEG Ratio
9.17
Balance Sheet Safety
N/A
Net Debt / Equity
1.24
N/A
Interest Coverage
N/A
2.03
Net Debt / EBITDA
5.40
2.35%
Dividend Yield
4.21%
ABBV: 5Ties: 1CPT: 2
ABBVCPT

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

CPT

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
CPT
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-395.7M
Δ Market Cap
$-206.6M
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
71.5% Overvalued
Price is 71.5% above estimated fair value
Current Price: $294.89
Fair Value: $172.00
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
CPT
217.6% Overvalued
Price is 217.6% above estimated fair value
Current Price: $100.69
Fair Value: $31.71
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

Requires positive FCF to compute implied growth rate.

CPT

What growth rate is the market pricing in at $101?

+13.1%
Market-Implied Owner Earnings Growth
Standard FCF implies +18.0%

The market implies +13.1% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +18.0%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
ABBV
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
CPT
56/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with revenue predictability as the key competitive advantage. Improving roic consistency would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
CPT
-2.77
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 77.4%Retail & Other 22.5%
No. of Institutional Holders5,303
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
CPT
Insiders 1.5%Institutions 105.6%
No. of Institutional Holders830
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
CPT
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
1
Sells (3M)
4
Sells (12M)
Total value (12M): $18.92M
DONOGHOE NICHOLAS
Officer
$8.18M
@ $250.00 · 2026-08-14
PURDUE DAVID RYAN
Officer
$1.22M
@ $233.56 · 2026-03-04
SIATIS PERRY C.
General Counsel
$4.38M
@ $234.39 · 2026-03-02
SIATIS PERRY C.
General Counsel
$5.15M
@ $230.00 · 2026-02-25
SALEKI-GERHARDT AZITA
Chief Operating Officer
$8.41M
@ $198.42 · 2025-08-12
DONOGHOE NICHOLAS
Officer
$2.64M
@ $198.51 · 2025-08-05
STEWART JEFFREY RYAN
Officer
$12.36M
@ $210.08 · 2025-03-31
REENTS SCOTT T.
Chief Financial Officer
$3.75M
@ $212.34 · 2025-03-14
GONZALEZ RICHARD A
Director
$20.26M
@ $205.45 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$4.47M
@ $210.45 · 2025-03-03
SIATIS PERRY C.
General Counsel
$5.82M
@ $208.69 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$6.07M
@ $202.90 · 2025-02-26
BUCKBEE KEVIN K
Officer
$3.85M
@ $203.41 · 2025-02-26
SIATIS PERRY C.
General Counsel
$1.14M
@ $197.90 · 2025-02-20
BUCKBEE KEVIN K
Officer
$310,032
@ $172.24 · 2024-12-16
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
CPT
0
Sells (3M)
10
Sells (12M)
Total value (12M): $9.61M
CAMPO RICHARD J
Officer and Director
$3.37M
@ $112.42 · 2026-06-05
BAKER LAURIE A.
Chief Operating Officer
$235,007
@ $108.40 · 2026-02-18
GALLAGHER MICHAEL P
Officer
$18,325
@ $108.43 · 2026-02-18
BAKER LAURIE A.
Chief Operating Officer
$74,827
@ $109.88 · 2026-01-06
CAMPO RICHARD J
Chief Executive Officer
$4.79M
@ $109.83 · 2026-01-06
JESSETT ALEXANDER J
President
$617,237
@ $109.69 · 2026-01-05
BRUNNER HEATHER J
Director
$230,792
@ $109.69 · 2026-01-05
WESTBROOK KELVIN R
Director
$244,065
@ $109.69 · 2026-01-05
BENITO JAVIER
Director
$11,079
@ $109.69 · 2026-01-05
WEBSTER STEVEN ALAN
Director
$16,814
@ $109.18 · 2026-01-02
WEBSTER STEVEN ALAN
Director
$142,512
@ $118.76 · 2025-05-16
CAMPO RICHARD J
Chief Executive Officer
$2.51M
@ $119.52 · 2025-05-07
GALLAGHER MICHAEL P
Officer
$16,495
@ $122.19 · 2025-03-10
BAKER LAURIE A.
Chief Operating Officer
$273,221
@ $118.38 · 2025-02-19
CAMPO RICHARD J
Chief Executive Officer
$5.36M
@ $119.07 · 2025-02-11
JESSETT ALEXANDER J
President
$1.70M
@ $113.95 · 2025-01-08
BRUNNER HEATHER J
Director
$241,233
@ $113.95 · 2025-01-08
CAMPO RICHARD J
Chief Executive Officer
$953,426
@ $113.95 · 2025-01-08
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😏Greed(72/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
CPT
FearGreed
😐Neutral(50/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (72)
CPT
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (50)
View ABBV Full AnalysisView CPT Full Analysis

Frequently Asked Questions: ABBV vs CPT

Is AbbVie Inc. or Camden Property Trust more undervalued in 2026?▼

Based on our discounted cash flow model, ABBV trades at a -71.5% margin of safety (intrinsic value $172 vs. price $295), compared to CPT's -217.6% margin of safety (intrinsic $32 vs. $101).

Which stock has a wider economic moat, AbbVie Inc. or Camden Property Trust?▼

ABBV scores 82/100 (Wide moat), while CPT scores 56/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is Camden Property Trust in financial distress?▼

CPT's Altman Z-Score of 1.6 places it in the Distress zone, signaling elevated bankruptcy risk. ABBV scores 2.4 (Grey zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, AbbVie Inc. or Camden Property Trust?▼

ABBV earns 29.1% ROIC versus CPT's 2.3%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, AbbVie Inc.'s or Camden Property Trust's?▼

ABBV's dividend earns a safety score of 39/100 (Unsafe), compared to CPT's 24/100 (Unsafe). ABBV has raised its dividend for 3 consecutive years.

ABBV vs CPT: Which Is the Better Buy in 2026? | SafetyMargin.io